One Global Service Provider Announces Strategic Diagnostics Acquisition

Transaction Value: Rs 39.54 crore (non-cash) via 715,040 new equity shares issued at Rs 553 per share.

Reader Takeaway: Acquisition boosts healthcare presence through inorganic growth, though shareholders face dilution from the new share issuance.

What just happened

One Global Service Provider Ltd has approved the acquisition of a 51% controlling stake in Matrix Labs Diagnocare Private Limited (MLDPL) and Matrix Labs Private Limited (MLPL). The total deal value of Rs 39.54 crore will be settled by issuing 715,040 equity shares to the sellers at an issue price of Rs 553 each. This move is part of a broader strategy to scale the company’s operations in the medical diagnostics and In-Vitro Diagnostics (IVD) sectors.

Why this matters

The acquisition allows the company to integrate established diagnostics businesses, potentially capturing operational synergies and diversifying its revenue streams. Alongside the acquisition, the board has proposed doubling the company's authorized share capital from Rs 25.05 crore to Rs 50 crore to accommodate the expansion.

Auditor and Governance Updates

The company has reappointed M/s. S D P M & Co. as Statutory Auditor for a second five-year term ending at the 39th AGM. Additionally, M/s. Valawat & Associates has been appointed as Internal Auditor for FY 2026-27, replacing M/s. Rushil Soni & Co., who resigned in August 2026.

Risks to watch

Investors should consider the dilution effect of the 715,040 new shares issued. Furthermore, the entire transaction, including the increase in authorized capital, remains subject to shareholder approval at the 34th AGM scheduled for September 29, 2026, as well as pending regulatory clearances.

What to track next

The primary event to watch is the 34th AGM on September 29, 2026. Shareholders should focus on the voting outcomes for the preferential issue and capital expansion, which are critical for the completion of the acquisition.